Alimta (Pemetrexed) – Oncology Drug

Pemetrexed – Oncology Drug Information Alimta is a novel antifolate compound with inhibitory activity against a number of enzymes including thymidilate synthase, dihydrofolate reductase and glycinamide ribonucleotide formyl transferase. Alimta has been studied with cis-platinum (Cisplatin) or gemcitabine (Gemzarâ) in the treatment of non-small-cell lung cancer (NSCLC). Phase II...

Mesothelioma Cancer

Mesothelioma cancer is an aggressive and invasive form of cancer, and it quickly spreads over the surface of the lungs, abdominal organs or heart. In the simplest terms, is a cancer of the mesothelium, the membrane that covers the organs in the body. It is a rare form of...